Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idacorp (IDA) Gains from Investment Securities (2016 - 2025)

Idacorp (IDA) has disclosed Gains from Investment Securities for 17 consecutive years, with -$5.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities fell 151.37% to -$5.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.6 million, a 134.25% increase, with the full-year FY2024 number at $25.2 million, up 754.24% from a year prior.
  • Gains from Investment Securities was -$5.9 million for Q3 2025 at Idacorp, down from $94000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $38.2 million in Q3 2022 to a low of -$26.6 million in Q4 2022.
  • A 5-year average of $2.6 million and a median of $94000.0 in 2025 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: plummeted 295.86% in 2021, then skyrocketed 2642.91% in 2022.
  • Idacorp's Gains from Investment Securities stood at $17.6 million in 2021, then tumbled by 250.97% to -$26.6 million in 2022, then skyrocketed by 115.02% to $4.0 million in 2023, then surged by 431.12% to $21.2 million in 2024, then crashed by 127.85% to -$5.9 million in 2025.
  • Per Business Quant, the three most recent readings for IDA's Gains from Investment Securities are -$5.9 million (Q3 2025), $94000.0 (Q2 2025), and $3.2 million (Q1 2025).